MSとはMultiple Sclerosis(多発性硬化症)のこと。この治療薬(http://mssociety.ca/en/treatments/modify.htm)は数多くありませんが、Gilenyaはそのひとつ。注意しておきたいのは、Vaccinations may be less effective during and for up to two months after fingolimod treatment. また、
Live attenuated vaccines are not recommended during
fingolimod treatment and for two months after discontinuing treatment, due to the risk of infection from the vaccine.
ということなので、
Vaccination for varicella zoster virus (VZV) is recommended prior to starting fingolimod treatment in patients without contraindications who have negative IgG antibody test results for VZV due to no previous exposure or vaccination. Fingolimod therapy should not be started until one month after VZV vaccination.
こういう滅多に見ない薬でもオスキーなどには出るかも知れませんので、MS societyのサイトでしっかり勉強しておきましょう。
[引用]
http://www.canadianhealthcarenetwork.ca/pharmacists/clinical/health-index-therapeutics/neurology/gilenya-new-ms-drug-approved-by-health-canada-10001
0 件のコメント:
コメントを投稿